Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBakkavor Regulatory News (BAKK)

Share Price Information for Bakkavor (BAKK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 120.00
Bid: 119.00
Ask: 120.00
Change: -3.00 (-2.44%)
Spread: 1.00 (0.84%)
Open: 123.50
High: 123.50
Low: 118.00
Prev. Close: 123.00
BAKK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

20 May 2021 15:26

RNS Number : 3409Z
Bakkavor Group PLC
20 May 2021
 

20 May 2021

Bakkavor Group plc

(the 'Company')

 

2021 Annual General Meeting - Poll Results

The Company's 2021 Annual General Meeting (AGM) was held today at 10.00 am at Fitzroy Place, 5th Floor, 8 Mortimer Street, London, W1T 3JJ. All resolutions set out in the Notice of AGM dated 20 April 2021 and put to the meeting were decided on by a poll and were passed.

 

Resolutions 1 to 17 were each passed as an Ordinary Resolution (requiring a simple majority for them to be passed) and resolutions 18 to 21 were each passed as a Special Resolution (requiring at least a 75% majority for them to be passed). The results for each resolution are set out below.

 

Resolution

Votes For

%

Votes Against

%

Total Votes Cast (Excluding Withheld)

% of ISC Voted *

Votes Withheld

1.

To receive the Annual Report and Accounts

560,770,998

99.85%

832,593

0.15%

561,617,542

97.00%

423,772

2.

To approve the Directors' Remuneration Report

556,221,222

98.97%

5,795,516

1.03%

562,030,689

97.00%

10,625

3.

To approve the Directors' Remuneration Policy

560,474,682

99.72%

1,552,056

0.28%

562,040,689

97.00%

625

4.

To declare a deferred final dividend on the ordinary shares of the Company for the year ended 28 December 2019 of 4 pence per share

562,026,563

100.00%

800

0.00%

562,041,314

97.00%

0

5.

To elect Ben Waldron as a Director of the Company

561,843,318

99.96%

184,045

0.03%

562,041,314

97.00%

0

6.

To elect Mike Edwards as a Director of the Company

561,859,341

99.97%

168,022

0.03%

562,041,314

97.00%

0

7.

To elect Umran Beba as a Director of the Company

562,012,469

99.99%

14,894

0.00%

562,041,314

97.00%

0

8.

To elect Jill Caseberry as a Director of the Company

561,911,521

99.98%

105,842

0.02%

562,031,314

97.00%

10,000

9.

To re-elect Simon Burke as a Director of the Company

561,058,393

99.83%

968,969

0.17%

562,041,313

97.00%

1

10.

To re-elect Agust Gudmundsson as a Director of the Company

561,863,570

99.97%

163,793

0.03%

562,041,314

97.00%

0

11.

To re-elect Denis Hennequin as a Director of the Company

561,994,829

99.99%

32,534

0.01%

562,041,314

97.00%

0

12.

To re-elect Jane Lodge as a Director of the Company

561,726,018

99.95%

291,345

0.05%

562,031,314

97.00%

10,000

13.

To re-elect Lydur Gudmundsson as a Director of the Company

556,083,842

98.94%

5,942,995

1.06%

562,041,314

97.00%

0

14.

To re-elect Patrick Cook as a Director of the Company

549,386,208

97.75%

12,640,629

2.25%

562,041,314

97.00%

0

15.

To re-appoint PricewaterhouseCoopers LLP as Auditors of the Company

560,130,095

99.66%

1,896,742

0.34%

562,041,314

97.00%

0

16.

To authorise the Audit and Risk Committee to determine the remuneration of the Auditord

562,025,587

100.00%

2,000

0.00%

562,041,314

97.00%

0

17.

To authorise the Directors to allot shares

559,090,974

99.48%

2,936,613

0.52%

562,041,314

97.00%

0

18.

To empower the Directors to disapply pre-emption rights

562,010,231

99.99%

16,139

0.00%

562,040,847

97.00%

467

19.

To empower the Directors to disapply pre-emption rights for financing/refinancing particular acquisitions and other capital investments

558,446,212

99.36%

3,580,157

0.64%

562,040,846

97.00%

468

20.

To authorise the Company to purchase its own shares

561,161,481

99.85%

842,112

0.15%

562,018,070

97.00%

23,244

21.

To allow a general meeting to be called on 14 clear days' notice

561,457,742

99.90%

568,895

0.10%

562,041,114

97.00%

200

 

* Based on total issued share capital as at 18 May 2021 of 579,425,585 Ordinary shares.

 

 

Votes of Independent Shareholders on the resolutions concerning the election and re-election of the Independent Non-executive Directors

Resolution

Votes For

%

Votes Against

%

Total Votes Cast

% of ISC Voted **

Votes Withheld

1.

To elect Umran Beba as a Director of the Company

127,514,781

99.98%

14,894

0.01%

127,543,626

88.00%

0

2.

To elect Jill Caseberry as a Director of the Company

127,413,833

99.91%

105,842

0.08%

127,533,626

88.00%

10,000

3.

To re-elect Simon Burke as a Director of the Company

126,560,705

99.23%

968,969

0.76%

127,543,625

88.00%

1

4.

To re-elect Denis Hennequin as a Director of the Company

127,497,141

99.96%

32,534

0.03%

127,543,626

88.00%

0

5.

To re-elect Jane Lodge as a Director of the Company

127,228,330

99.76%

291,345

0.23%

127,533,626

88.00%

10,000

 

** Based on independent voting capital of 144,927,897, being total issued share capital of 579,425,585 Ordinary shares as at 18 May 2021, but excluding shares held by the controlling shareholders.

 

Notes:

a) The votes "For" and "Against" are expressed as a percentage of the votes received.

b) Proxy appointments which gave discretion to the Chairman of the Meeting have been included in the "For" total.

c) The Company's issued share capital as at 18 May 2021 is 579,425,585 ordinary shares of 2 pence each.

d) The Company's issued share capital as at 20 May 2021 is 579,425,585 ordinary shares of 2 pence each.

e) A "Vote Withheld" is not counted towards the votes cast "For" or "Against" a resolution.

f) In accordance with Listing Rule 9.2.2E, Resolutions 7-9, 11 and 12, inclusive were approved by: (a) the shareholders of the Company; and (b) the independent shareholders of the Company.

g) In accordance with Listing Rule 9.6.2, a copy of all resolutions passed other than resolutions concerning ordinary business will be submitted to the FCA via the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

ENQUIRIES

Institutional investors and analysts:

Emily Daw, Head of Investor Relations  +44 (0) 20 7908 6114

Annabel Tagoe-Bannerman, Group General Counsel & Company Secretary +44 (0) 20 7908 6130

Media:

Will Palfreyman, Tulchan Communications +44 (0) 20 7353 4200

ABOUT BAKKAVOR

Bakkavor is the leading provider of fresh prepared food ("FPF") in the UK, with a growing international presence in the US and China. The Group is the number one by market share in the UK in the four FPF product categories of meals, salads, desserts and pizza & bread, providing high-quality, fresh, healthy and convenient food. Its customers include some of the UK's leading grocery retailers, including Tesco, Marks & Spencer, Sainsbury's and Waitrose. The Group's International segment operates in the US and China. Bakkavor was founded in 1986 and has its headquarters in London. The Group has over 19,000 employees and operates 23 factories in the UK, 5 in the US and 9 in China.

 

LEI number: 213800COL7AD54YU9949 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGURUSRASUVUAR
Date   Source Headline
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
2nd Apr 20241:15 pmRNSDirector Declaration
26th Mar 20241:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSAnnual Report and Accounts 2023 and Notice of AGM
5th Mar 20244:56 pmRNSFinal Dividend for Full Year 2023
5th Mar 20247:00 amRNSFull Year Results 2023
18th Jan 20247:00 amRNSFull Year 2023 Trading Update
15th Jan 20247:17 amRNSMajor Shareholder Change and Directorate Change
15th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20243:48 pmRNSHolding(s) in Company
9th Oct 20233:37 pmRNSDirector/PDMR Shareholding
21st Sep 202312:07 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSHalf-year Report
20th Jul 202310:07 amRNSDirector Declaration
31st May 20233:11 pmRNSResult of AGM
31st May 20237:00 amRNSQ1 2023 Trading Update
23rd May 20237:00 amRNSDirector/PDMR Shareholding
10th May 20235:16 pmRNSDirector/PDMR Shareholding
13th Apr 20239:54 amRNSDirector/PDMR Shareholding
3rd Apr 20234:05 pmRNSDirector/PDMR Shareholding
29th Mar 202311:57 amRNSHolding(s) in Company
17th Mar 20237:00 amRNSAnnual Report and Accounts 2022 and Notice of AGM
8th Mar 20237:00 amRNSFull Year Results 2022
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSFull year 2022 trading update
18th Jan 20236:00 pmRNSRPS Group
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSQ3 2022 trading update
18th Nov 20227:00 amRNSBoard Committee Membership Changes
13th Oct 20224:05 pmRNSDirector/PDMR Shareholding
10th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSDirectorate Change
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 20224:36 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20224:41 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jun 20224:36 pmRNSPrice Monitoring Extension
7th Jun 20227:30 amRNSDirector Declaration
30th May 20224:36 pmRNSPrice Monitoring Extension
27th May 20222:03 pmRNSDirector/PDMR Shareholding
25th May 20223:09 pmRNSResult of AGM
25th May 20221:38 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSQ1 2022 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.